601 related articles for article (PubMed ID: 35568865)
1. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin.
Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF
J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865
[TBL] [Abstract][Full Text] [Related]
2. Cyclodextrin-Derived ROS-Generating Nanomedicine with pH-Modulated Degradability to Enhance Tumor Ferroptosis Therapy and Chemotherapy.
Xu M; Zha H; Han R; Cheng Y; Chen J; Yue L; Wang R; Zheng Y
Small; 2022 May; 18(20):e2200330. PubMed ID: 35451223
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis triggered by dihydroartemisinin facilitates chlorin e6 induced photodynamic therapy against lung cancerthrough inhibiting GPX4 and enhancing ROS.
Han N; Li LG; Peng XC; Ma QL; Yang ZY; Wang XY; Li J; Li QR; Yu TT; Xu HZ; Xu X; Chen X; Wang MF; Li TF
Eur J Pharmacol; 2022 Mar; 919():174797. PubMed ID: 35122867
[TBL] [Abstract][Full Text] [Related]
4. α-Fe
Xu Y; Xiao L; Chen J; Wu Q; Yu W; Zeng W; Shi Y; Lu Y; Liu Y
Acta Biomater; 2022 Sep; 150():367-379. PubMed ID: 35917907
[TBL] [Abstract][Full Text] [Related]
5. Peroxide-Simulating and GSH-Depleting Nanozyme for Enhanced Chemodynamic/Photodynamic Therapy via Induction of Multisource ROS.
Liu G; Liu M; Li X; Ye X; Cao K; Liu Y; Yu Y
ACS Appl Mater Interfaces; 2023 Oct; 15(41):47955-47968. PubMed ID: 37812458
[TBL] [Abstract][Full Text] [Related]
6. Fe-MnO
Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X
Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713
[TBL] [Abstract][Full Text] [Related]
7. A Dihydroartemisinin-Loaded Nanoreactor Motivates Anti-Cancer Immunotherapy by Synergy-Induced Ferroptosis to Activate Cgas/STING for Reprogramming of Macrophage.
Li LG; Yang XX; Xu HZ; Yu TT; Li QR; Hu J; Peng XC; Han N; Xu X; Chen NN; Chen X; Tang JM; Li TF
Adv Healthc Mater; 2023 Nov; 12(28):e2301561. PubMed ID: 37567571
[TBL] [Abstract][Full Text] [Related]
8. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy.
Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S
J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750
[TBL] [Abstract][Full Text] [Related]
9. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy.
Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S
Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032
[TBL] [Abstract][Full Text] [Related]
10. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu
Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z
Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045
[TBL] [Abstract][Full Text] [Related]
12. A pH-sensitive imidazole grafted polymeric micelles nanoplatform based on ROS amplification for ferroptosis-enhanced chemodynamic therapy.
Zhang Z; Wang L; Guo Z; Sun Y; Yan J
Colloids Surf B Biointerfaces; 2024 May; 237():113871. PubMed ID: 38547796
[TBL] [Abstract][Full Text] [Related]
13. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO
Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R
Acta Biomater; 2024 May; ():. PubMed ID: 38801869
[TBL] [Abstract][Full Text] [Related]
14. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells.
Chen Y; Mi Y; Zhang X; Ma Q; Song Y; Zhang L; Wang D; Xing J; Hou B; Li H; Jin H; Du W; Zou Z
J Exp Clin Cancer Res; 2019 Sep; 38(1):402. PubMed ID: 31519193
[TBL] [Abstract][Full Text] [Related]
15. A tumor pH-responsive autocatalytic nanoreactor as a H
Liu F; He T; Gong S; Shen M; Ma S; Huang X; Li L; Wang L; Wu Q; Gong C
Acta Biomater; 2022 Dec; 154():510-522. PubMed ID: 36241016
[TBL] [Abstract][Full Text] [Related]
16. DHA exhibits synergistic therapeutic efficacy with cisplatin to induce ferroptosis in pancreatic ductal adenocarcinoma via modulation of iron metabolism.
Du J; Wang X; Li Y; Ren X; Zhou Y; Hu W; Zhou C; Jing Q; Yang C; Wang L; Li H; Fang L; Zhou Y; Tong X; Wang Y
Cell Death Dis; 2021 Jul; 12(7):705. PubMed ID: 34262021
[TBL] [Abstract][Full Text] [Related]
17. An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy.
Huang S; Le H; Hong G; Chen G; Zhang F; Lu L; Zhang X; Qiu Y; Wang Z; Zhang Q; Ouyang G; Shen J
Acta Biomater; 2022 Aug; 148():244-257. PubMed ID: 35709941
[TBL] [Abstract][Full Text] [Related]
18. Iron nitroprusside as a chemodynamic agent and inducer of ferroptosis for ovarian cancer therapy.
Asif K; Adeel M; Rahman MM; Caligiuri I; Perin T; Cemazar M; Canzonieri V; Rizzolio F
J Mater Chem B; 2023 Apr; 11(14):3124-3135. PubMed ID: 36883303
[TBL] [Abstract][Full Text] [Related]
19. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of cervical cancer to dihydroartemisinin-induced ferritinophagy-dependent ferroptosis.
Shi H; Xiong L; Yan G; Du S; Liu J; Shi Y
Front Mol Biosci; 2023; 10():1156062. PubMed ID: 37065442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
